Company profile
bioAffinity Technologies, Inc.
NASDAQ:BIAFBiotechnology: Commercial Physical & Biological Resarch
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.